Cognitive Enhancement Research Dihexa Dihexa has been directly tested in cognitive paradigms (aged rat water maze, scopolamine reversal) and demonstrates synaptogenesis through HGF/c-Met signaling, providing a more direct cognitive enhancement rationale than PE-22-28 Neurogenesis and Mood Research PE-22-28 PE-22-28 induces hippocampal neurogenesis within 4 days and demonstrates antidepressant-like effects through TREK-1 blockade, making it more relevant for mood-cognition intersection research Oral Bioavailability Requirement Dihexa Dihexa has demonstrated approximately 38% oral bioavailability with BBB penetration, while PE-22-28 oral availability has not been characterized Lower Theoretical Risk Profile PE-22-28 PE-22-28 targets an ion channel without known oncological associations, whereas Dihexa activates the HGF/c-Met pathway which is a characterized oncogenic signaling axis Evidence Reliability PE-22-28 PE-22-28 has no retracted publications in its evidence base, while a key 2014 Dihexa paper was retracted for data fabrication concerns Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly

Social Life of senescent cells: what Is SASP and why study it
You should not consider Phentermine under these circumstances: If you have a history of heart disease, stroke, or irregular heart rhythms, avoid Phentermine because the medication can increase the risk of serious heart problems
TB-500: Preclinical studies show accelerated wound closure, reduced fibrosis, and improved function after ischemic or traumatic injuries [1] [2]
They work through different mechanisms, which is exactly why theyre so often studied side by side and increasingly as a single combined blend
Zero human trials